Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hisae, Eguchi"'
Autor:
Kojiro Shimozuma, Nobuko Ushirozawa, Hisae Eguchi, Yasuo Ohashi, Kenji Eguchi, Kenichi Ishizawa, Yuko Saito, Izumi Wasada, Satoshi Morita, Maya Kurita, Yuki Fujiki
Publikováno v:
Supportive Care in Cancer. 15:1-6
The purpose of this study was to reveal the clinical validity of the Japanese version of the Functional Assessment of Cancer Therapy-Anemia scale (FACT-An) in relation to hemoglobin level. We also analyzed patients' scores for the related FACT-Genera
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 32:314-319
The large dose administration of the carcinostatic agent methotrexate (MTX), a folic acid antagonist, is effective in treating osteosarcoma but its use is often accompanied by critical adverse effects. Forty-eight hours after administering MTX to a 9
Publikováno v:
Japanese Journal of Hospital Pharmacy. 21:572-583
Patients who have cancer usually suffer from significant pain the controling of which is a vital problem. Drug therapy with opiate analgesics, especially morphine which is a mainstay of therapy for the patients with cancer-related pain. Morphine is e
Autor:
Izumi, Wasada, Hisae, Eguchi, Maya, Kurita, Shitomi, Kudo, Tomoko, Shishida, Yaeko, Mishima, Yuko, Saito, Nobuko, Ushiorozawa, Takashi, Seto, Kojiro, Shimozuma, Satoshi, Morita, Mari, Saito, Yuki, Yokomizo, Kenichi, Ishizawa, Yasuo, Ohashi, Kenji, Eguchi
Publikováno v:
The Tokai journal of experimental and clinical medicine. 38(1)
The Functional Assessment of Cancer Therapy-Anemia (FACT-An) was developed to measure the effect of anemia on quality of life (QOL) in cancer patients. We have previously validated the Japanese version of the FACT-An in Japanese cancer patients recei
Autor:
Hisashi, Tagashira, Tetsuaki, Matsuhisa, Isao, Oze, Sachiko, Kiyoto, Mina, Takahashi, Fumikata, Hara, Daisuke, Takabatake, Seiki, Takashima, Kenjiro, Aogi, Shozo, Osumi, Hisae, Eguchi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 38(8)
We retrospectively analyzed the efficacy and safety of aprepitant in breast cancer patients who were treated with FEC(5- fluorouracil, epirubicin, cyclophosphamide)or EC(epirubicin, cyclophosphamide). We divided patients into two groups according to
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 37(1)
Paclitaxel (PTX) is one of the most important breast cancer treatment drugs. However, severe hypersensitivity reactions such as decreases in blood pressure and impaired breathing occur with high frequency. For the prevention of such hypersensitivity
Publikováno v:
Pharmacy worldscience : PWS. 32(6)
This study was undertaken to investigate the relationship between the plasma concentration of morphine, morphine-3-glucuronide and morphine-6-glucuronide and pain in cancer patients receiving oral morphine.The trough value of plasma concentrations of
Autor:
Hisae Eguchi
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 41:87S-88S
Autor:
HISAE EGUCHI
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 34:431S-432S
Autor:
Maya Kurita, Kojiro Shimozuma, Satoshi Morita, Yuki Fujiki, Kenichi Ishizawa, Hisae Eguchi, Yuko Saito, Nobuko Ushirozawa, Izumi Wasada, Yasuo Ohashi, Kenji Eguchi
Publikováno v:
Supportive Care in Cancer; Jan2007, Vol. 15 Issue 1, p1-6, 6p